Erasca Inc Stock In The News

ERAS Stock  USD 2.92  0.14  5.04%   
Our overall analysis of Erasca's news coverage and content from conventional and social sources shows investors' bearish mood towards Erasca Inc. The specific impact of Erasca news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Erasca's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Erasca headlines in addition to utilizing other, more conventional financial analysis modules. Check out Erasca Backtesting and Erasca Hype Analysis.

Erasca Today Top News and Investor Outlook

Yahoo News
Erasca Announces Two Clinical Trial Coll...
https://finance.yahoo.com/news/erasca-announces-two-clinical-trial-130000133.html
 Neutral
Yahoo News
3 Penny Stocks You’ll Regret Not Buying Soon: December Edition
https://finance.yahoo.com/news/3-penny-stocks-ll-regret-183400670.html
 Bullish
Macroaxis News: globenewswire.com
Erasca Achieves Key Milestones for Naporafenib and ERAS-801 Programs and Extends Cash Runway
https://www.globenewswire.com/news-release/2023/11/28/2786879/0/en/Erasca-Achieves-Key-Milestones-for-Naporafenib-and-ERAS-801-Programs-and-Extends-Cash-Runway.html
 Neutral
Macroaxis News: globenewswire.com
Erasca Reports Third Quarter 2023 Financial Results and Business Updates
https://www.globenewswire.com/news-release/2023/11/09/2777784/0/en/Erasca-Reports-Third-Quarter-2023-Financial-Results-and-Business-Updates.html
 Neutral
Macroaxis News: globenewswire.com
Erasca to Present at Upcoming Investor Conferences in November
https://www.globenewswire.com/news-release/2023/11/08/2776170/0/en/Erasca-to-Present-at-Upcoming-Investor-Conferences-in-November.html
 Neutral
Macroaxis News: globenewswire.com
Erasca to Present at the Cantor Global Healthcare Conference
https://www.globenewswire.com/news-release/2023/09/19/2745546/0/en/Erasca-to-Present-at-the-Cantor-Global-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Erasca to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
https://www.globenewswire.com/news-release/2023/09/05/2737248/0/en/Erasca-to-Present-at-the-Morgan-Stanley-21st-Annual-Global-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Erasca Doses First Patient in SEACRAFT-1 Phase 1b Trial Evaluating Naporafenib Plus Trametinib in Patients with RAS Q61X Solid Tumors
https://www.globenewswire.com/news-release/2023/08/29/2733335/0/en/Erasca-Doses-First-Patient-in-SEACRAFT-1-Phase-1b-Trial-Evaluating-Naporafenib-Plus-Trametinib-in-Patients-with-RAS-Q61X-Solid-Tumors.html
 Neutral
Macroaxis News: globenewswire.com
Erasca Reports Second Quarter 2023 Financial Results and Business Updates
https://www.globenewswire.com/news-release/2023/08/10/2723112/0/en/Erasca-Reports-Second-Quarter-2023-Financial-Results-and-Business-Updates.html
 Neutral
Macroaxis News: globenewswire.com
Erasca Granted FDA Orphan Drug Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 for the Treatment of Malignant Glioma
https://www.globenewswire.com/news-release/2023/06/22/2693304/0/en/Erasca-Granted-FDA-Orphan-Drug-Designation-for-CNS-Penetrant-EGFR-Inhibitor-ERAS-801-for-the-Treatment-of-Malignant-Glioma.html
 Neutral

Erasca Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Erasca and other traded companies coverage with news coverage. We help investors stay connected with Erasca headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Erasca Stock performance. Please note that trading solely based on the Erasca Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Erasca's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Erasca Inc investors visualize upcoming and past events in order to time the market based on Erasca Inc noise-free hype analysis.
Erasca stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Erasca earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Erasca that are available to investors today. That information is available publicly through Erasca media outlets and privately through word of mouth or via Erasca internal channels. However, regardless of the origin, that massive amount of Erasca data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Erasca news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Erasca relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Erasca's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Erasca alpha.

Erasca Largest EPS Surprises

Earnings surprises can significantly impact Erasca's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-08
2024-03-31-0.2-0.23-0.0315 
2024-03-27
2023-12-31-0.23-0.20.0313 
2023-08-10
2023-06-30-0.24-0.210.0312 
2024-11-13
2024-09-30-0.1671-0.110.057134 
2022-03-24
2021-12-31-0.34-0.260.0823 
2023-05-15
2023-03-31-0.31-0.220.0929 
View All Earnings Estimates

Erasca Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Erasca Inc Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
zacks News
15th of November 2024
Erasca May Find a Bottom Soon, Heres Why You Should Buy the Stock Now
at zacks.com 
Google News at Macroaxis
5th of November 2024
Erasca to Present at Three Major Healthcare Investor Conferences ERAS Stock News - StockTi...
at news.google.com 
news
28th of October 2024
Taylor Swift fans praise her response to major stage malfunction
at aol.com 
Yahoo News
24th of October 2024
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
at finance.yahoo.com 
Simply Wall St News at Macroaxis
15th of October 2024
We Think Erasca Can Afford To Drive Business Growth
at simplywall.st 
Macroaxis News
26th of September 2024
Acquisition by Garner Ebun of 480000 shares of Erasca at 1.7 subject to Rule 16b-3
at MacroaxisInsider 
Simply Wall St News at Macroaxis
10th of September 2024
Erasca Insiders Enjoying US2.5m Appreciation On US3.97m Investment
at simplywall.st 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Erasca in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Erasca's short interest history, or implied volatility extrapolated from Erasca options trading.

Additional Tools for Erasca Stock Analysis

When running Erasca's price analysis, check to measure Erasca's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Erasca is operating at the current time. Most of Erasca's value examination focuses on studying past and present price action to predict the probability of Erasca's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Erasca's price. Additionally, you may evaluate how the addition of Erasca to your portfolios can decrease your overall portfolio volatility.